Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.

Morris, Patrick G

Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases. [electronic resource] - Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Dec 2012 - 2768-75 p. digital

Publication Type: Journal Article

1531-5053

10.1016/j.joms.2011.12.028 doi


Adult
Aged
Aged, 80 and over
Alkaline Phosphatase--analysis
Biomarkers--blood
Bisphosphonate-Associated Osteonecrosis of the Jaw--blood
Bone Density Conservation Agents--administration & dosage
Bone Neoplasms--drug therapy
Bone and Bones--enzymology
Breast Neoplasms--pathology
Collagen Type I--blood
Diphosphonates--administration & dosage
Female
Follow-Up Studies
Forecasting
Humans
Male
Middle Aged
Peptides--blood
Prostatic Neoplasms--pathology
Retrospective Studies
Time Factors